|
Market Cap (20-May) $14,687,399 (777th) |
Close (30-Jun) $0.018 |
Volume (30-Jun) 1,123,417 |
Shortsold (11-Sep) 1,800,000 (0.12%) (439th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E 20.00 |
EPS -0.02 |
BNO released this announcement to the ASX on 29 January 2021, 9:40. The announcement is marked as price sensitive, and is 9 page(s) in length and 360.92kb in size.
You can view all announcements from BNO and see how they appear on a price chart on the announcements page.
At the date of this announcement, BNO was 0.002% short sold according to ASIC data. It was ranked the 643rd most shorted stock on the ASX. It is now ranked as the 439th most shorted stock on the ASX with 0.123% of total shares short sold as of the latest reported data (11 September 2023).
| Other Recent Announcements from BNO | |
|---|---|
| Poster Presentation at the ASCP Annual Meeting | 1 June 2023, 9:16 |
| Corporate Presentation - May 2023 | 23 May 2023, 9:24 |
| BNO announces establishment of At-The-Market Equity Program | 8 May 2023, 8:54 |
| Appendix 4C - quarterly | 29 January 2021, 9:40 |
| BNC105 / Nivolumab Treatment Completed in Phase 2 Trial | 20 January 2021, 10:19 |
| Publication of Positive BNC210 Phase 2a Data in GAD Patients | 18 January 2021, 10:26 |
| BNO Presenting at H.C. Wainwright BioConnect 2021 Conference | 7 January 2021, 14:38 |
You must be logged in to post a reply.
Bionomics 